Fig. 1
Overall survival of 144 patients with either “chronic phase primary myelofibrosis with 5–19% peripheral blood (PB) blasts” or “blast phase primary myelofibrosis (PMF-BP)”
Fig. 1 | Blood Cancer Journal
Overall survival of 144 patients with either “chronic phase primary myelofibrosis with 5–19% peripheral blood (PB) blasts” or “blast phase primary myelofibrosis (PMF-BP)”
